Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT AURINIA PHARMACEUTICALS INC

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH)
Listen to this Section


$16.12
-0.2500 ( -1.53% ) 602.0K

Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing LUPKYNIS (voclosporin), an investigational drug, for the treatment of lupus nephritis (LN), and others. Geographically, it derives maximum revenue from the United States.

Market Data


Open $16.12
Previous Close $16.37
Volume 602.0K
Market Cap $2.11B
Day Range $16.11 - $16.67
52 Week Range $7.29 - $16.88
Shares Outstanding 128.60M
Change % -1.53%
Net Change ▼ -0.2500
Insider Ownership 0.02%
Exchange NASDAQ
SectorMiscellaneous
IndustryNone
IPO Year2009
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: 951,738.00

Date Type Amount Purchased Purchaser
2024-03-07 Sale -40665.00 Donley Matthew Maxwell
2024-03-07 Sale -17777.00 Habig Scott Michael
2024-03-07 Sale -57745.00 Robertson Stephen P.
2024-02-29 Sale -4930.00 Knappertz Volker
2024-02-22 Sale -25146.00 Knappertz Volker

SEC Filings


Form Type Description Pages Date
10-q Quarterly Reports 61 Nov 04, 2025
8-k 8K-related 42 Nov 04, 2025
4 Insider transactions 1 Aug 05, 2025
4 Insider transactions 1 Aug 05, 2025
8-k 8K-related 14 Jul 31, 2025
10-q Quarterly Reports 63 Jul 31, 2025
8-k 8K-related 31 Jun 30, 2025

Latest News


× Before browsing our site, please accept our cookies policy